Jorn Drappa
Chief Medical Officer · ALUMIS INC.
IndividualSelling only
- 2025
- Aug 5, 2026
- 4
Filings (90d)
1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jorn Drappa files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Srinivas Akkaraju - $28.98M in ALMS purchases and sales in the last 12 months
- Foresite Labs, LLC - $3.63M in ALMS purchases and sales in the last 12 months
- James B. Tananbaum - $3.63M in ALMS purchases and sales in the last 12 months
- Foresite Capital Management VI LLC - $3.63M in ALMS purchases and sales in the last 12 months
- Sanam Pangali - $176K in ALMS purchases and sales in the last 12 months
- John R. Schroer - $87K in ALMS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jorn Drappa?
Jorn Drappa is a corporate insider, tracked as Chief Medical Officer of ALUMIS INC. (ALMS). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jorn Drappa submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jorn Drappa been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($65K) across all tracked filings.
